Sep 2, 2025 07:32AM
Sep 2, 2025 07:30AM
Aug 11, 2025 09:26AM
Aug 11, 2025 09:26AM
Jun 18, 2025 08:00AM
May 2, 2023 07:30AM
Apr 3, 2023 07:00AM Revive Therapeutics Advances MDMA Transdermal Patch Development with Purchase of MDMA Supply from PharmAla Biotech
Mar 29, 2023 07:30AM
Feb 7, 2023 07:59AM
Feb 6, 2023 08:00AM
Feb 2, 2023 07:30AM
Feb 1, 2023 11:25AM
Jan 18, 2023 08:15AM
Jan 11, 2023 08:15AM PharmaTher Holdings Provides Update for KETARX™ (Racemic Ketamine) Development Programs and Expected Milestones for 2023
Dec 15, 2022 07:59AM
Nov 14, 2022 07:59AM
Nov 1, 2022 07:00AM
Oct 5, 2022 07:00AM
Sep 29, 2022 07:00AM
Sep 16, 2022 07:00AM
Sep 7, 2022 07:00AM PharmaTher Announces Completion of IND-Enabling Pharmacokinetic and Tolerability Study with KETARX™ Ketamine Patch
Jul 13, 2022 07:00AM
Jun 29, 2022 07:00AM
Jun 7, 2022 07:00AM
May 25, 2022 07:00AM
May 5, 2022 07:00AM
Apr 25, 2022 05:06PM
Apr 12, 2022 07:00AM PharmaTher Signs Exclusive Worldwide License Agreement for Patented Formulation and Production Process of Ketamine and Ketamine Analogs
Mar 23, 2022 07:00AM
Mar 1, 2022 08:19AM
Feb 16, 2022 07:00AM
Feb 1, 2022 07:00AM
Jan 17, 2022 08:17AM
Jan 12, 2022 07:00AM
Jan 4, 2022 07:00AM PharmaTher Announces Publication of Research Data for KETABET™
Dec 21, 2021 07:00AM
Dec 20, 2021 07:00AM
Dec 14, 2021 07:00AM
Nov 30, 2021 07:00AM
Nov 24, 2021 07:30AM
Nov 11, 2021 07:59AM
Nov 3, 2021 07:30AM PharmaTher Enters into Research Collaboration Agreement with Revive Therapeutics for Development of Psilocybin Microneedle Patch
Nov 3, 2021 07:00AM
Nov 1, 2021 09:30AM
Oct 27, 2021 05:34PM
Oct 27, 2021 08:49AM
Oct 19, 2021 07:00AM
Oct 13, 2021 07:00AM
Oct 6, 2021 09:03AM PharmaTher Initiates Phase 2 Clinical Trial of Ketamine for the Treatment of Parkinson’s Disease
Sep 29, 2021 11:20AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All